GALANTAMINE SR SCP galantamine (as hydrobromide) 8mg modified release capsules blister pack

Country: Ավստրալիա

language: անգլերեն

source: Department of Health (Therapeutic Goods Administration)

active_ingredient:

galantamine hydrobromide, Quantity: 10.252 mg (Equivalent: galantamine, Qty 8 mg)

MAH:

Southern Cross Pharma Pty Ltd

INN:

Galantamine hydrobromide

pharmaceutical_form:

Capsule, modified release

composition:

Excipient Ingredients: magnesium stearate; ethylcellulose; titanium dioxide; hypromellose; Gelatin; microcrystalline cellulose

administration_route:

Oral

units_in_package:

28

prescription_type:

(S4) Prescription Only Medicine

therapeutic_indication:

Galantamine is indicated for the treatment of mild to moderately severe dementia of the Alzheimer type

leaflet_short:

Visual Identification: opaque white-white size 2 hard gelatin capsule containing one round biconvex tablet; Container Type: Blister Pack; Container Material: PVC/PE/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

authorization_status:

Licence status A

authorization_date:

2012-01-20